Skip to content
Trial Eligibility
Menu

Modafinil to Optimize the Performance of Cold-Stressed Sleep-Deprived Personnel

NCT07830056

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Environmental and workplace stressors are common and often unavoidable in military operations. Two critical stressors are cold stress and sleep loss. They both can substantially degrade operational effectiveness. Various countermeasures are available to mitigate the adverse effects of these stressors, but due to operational requirements many are of limited use in the field. Modafinil is a drug that mitigates the effects of sleep deprivation and potentially cold stress, and modafinil may prevent performance degradation due to the combination of these stressors.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Sleep Deprivation
  • Cold Exposure

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
17 to 39 years
Sex
All
Healthy volunteers
Accepted
Sponsor
United States Army Research Institute of Environmental Medicine
Last updated on ClinicalTrials.gov
September 21, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • US Army Research Institute of Environmental Medicine · Natick, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.